Clinically, the progressive nature of T2D is linked to beta cell dysfunction and loss, with patients lacking the ability to produce sufficient endogenous insulin to counteract insulin resistance and to control blood glucose levels49. The gene discussed is INS; the disease is type 2 diabetes mellitus.